Skip to main content
BrainCited

Alpha-GPC için Neurotransmitter Imbalance

B

Alpha-GPC provides 40% choline bioavailability, directly supporting acetylcholine synthesis — the primary neurotransmitter for learning and memory. Clinical studies in elderly patients show improvements in cognitive function scores.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Dalpha\u002Dgpc\u0026condition\u003Dneurotransmitter\u002Dimbalance'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Sonuç

Alpha-GPC provides 40% choline bioavailability, directly supporting acetylcholine synthesis — the primary neurotransmitter for learning and memory. Clinical studies in elderly patients show improvements in cognitive function scores.

Key Study Findings

Randomized Controlled Trial
Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized …
Dose: None vs: None Outcome: Cognitive decline Etki: None None

Popülasyon: Alzheimer's disease patients

Review
Choline supplements: An update.
Dose: alpha-GPC, choline bitartrate, lecithin, citicoline vs: None Outcome: Cognitive and muscular performance Etki: None None

Popülasyon: General population (review)

Key Statistics

10

Çalışmalar

800

Katılımcılar

Positive

B

Derece

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Yaygın Kullanılan Dozajlar

general:
300-600 mg/day
cognitivesupport:
600-1,200 mg/day

Üst sınır: Not established; well-tolerated up to 1,200 mg/day

Araştırmalarda İncelenen Dozajlar

Dozaj Süre Etki N
None -- Positive --
alpha-GPC, choline bitartrate, lecithin, citicoline -- Positive --

En iyi alım zamanı: Morning or split dose; with or without food

Safety & Side Effects

Bildirilen Yan Etkiler

  • Headache
  • Insomnia
  • Dizziness
  • Gastrointestinal discomfort
  • Fishy body odor at high doses (TMAO conversion)

Bilinen Etkileşimler

  • Anticholinergic medications (opposes Alpha-GPC effects)
  • Cholinesterase inhibitors (additive cholinergic effects)
  • Scopolamine (opposes cholinergic effects)

Tolere edilebilir üst alım: Not established; well-tolerated up to 1,200 mg/day

Herhangi bir takviye kullanmaya başlamadan önce mutlaka sağlık uzmanınıza danışın.Herhangi bir takviye başlatmadan önce her zaman sağlık uzmanınıza danışın.

Frequently Asked Questions

Does Alpha-GPC help with Neurotransmitter Imbalance?
Based on 10 studies with 800 participants, there is moderate evidence from clinical studies that Alpha-GPC may support Neurotransmitter Imbalance management. Our evidence grade is B (Good Evidence).
How much Alpha-GPC should I take for Neurotransmitter Imbalance?
Studies have used various dosages. A commonly studied range is 300-600 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Alpha-GPC?
Reported side effects may include Headache, Insomnia, Dizziness, Gastrointestinal discomfort. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Alpha-GPC and Neurotransmitter Imbalance?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 800 total participants. The overall direction of effect is positive.

Related Evidence

Şu durum için diğer içerikler: Neurotransmitter Imbalance

Alpha-GPC diğer sağlık durumları için

FDA Sorumluluk Reddi: Bu ifadeler Gıda ve İlaç Dairesi (FDA) tarafından değerlendirilmemiştir. Bu web sitesindeki ürünler ve bilgiler herhangi bir hastalığı teşhis etmek, tedavi etmek, iyileştirmek veya önlemek amacıyla tasarlanmamıştır. Sunulan kanıt dereceleri, yayımlanmış hakemli araştırmalarımızın analizine dayanmaktadır ve tıbbi tavsiye niteliği taşımamaktadır. Herhangi bir takviye rejimine başlamadan önce her zaman sağlık uzmanınıza danışın.